Zachary B Davis - JoVE Visualize

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Nature Medicine|February 1, 2022

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trialJeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.

JCI Insight|June 5, 2025

Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIVJoshua Rhein, Jeffrey G Chipman, Gregory J Beilman, et al.

Journal for Immunotherapy of Cancer|July 24, 2025

Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, et al.

Cell Stem Cell|September 15, 2021

Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune V Woan, Hansol Kim, Ryan Bjordahl, et al.

Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Nature Medicine|February 1, 2022

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trialJeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.

JCI Insight|June 5, 2025

Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIVJoshua Rhein, Jeffrey G Chipman, Gregory J Beilman, et al.

Journal for Immunotherapy of Cancer|July 24, 2025

Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, et al.

Cell Stem Cell|September 15, 2021

Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapyKarrune V Woan, Hansol Kim, Ryan Bjordahl, et al.

Pageof 3